TrademarkDir
IQIRVO
LIVE

Serial Number

79261272

Owner

GENFIT

Attorney

Ronald M. Kachmarik

Filing Date

Apr 8, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

IQIRVO Trademark

Serial Number: 79261272 • Registration: 6055569

IQIRVO is a trademark filed by GENFIT on April 8, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

GENFIT (44 trademarks)

885 rue Eugene Avinee
Loos 59120 , FR

Entity Type: 03

Trademark Details

Filing Date

April 8, 2019

Registration Date

May 19, 2020

Published for Opposition

March 3, 2020

Goods & Services

Pharmaceutical and veterinary preparations for the prevention and treatment of liver diseases, metabolic diseases, gastroenterological diseases, inflammatory diseases, immune disorders and cancers; chemical reagents for medical or pharmaceutical use; diagnostic preparations for medical purposes; diagnostic testing agents and substances for medical purposes; radio-isotope markers for therapeutics or diagnostic use

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
May 19, 2026 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
May 19, 2026 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 18, 2026 APRE
TEAS SECTION 71 & 15 RECEIVED
Jan 29, 2026 ES75
NEW REPRESENTATIVE AT IB RECEIVED
Jun 19, 2025 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 19, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
May 8, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 11, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 23, 2020 FICS
FINAL DISPOSITION PROCESSED
Sep 23, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 19, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
May 19, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Feb 28, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 12, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 12, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 12, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 28, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 17, 2020 XAEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 17, 2020 CRFA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 17, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 17, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 17, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 14, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 14, 2020 CRFA
ASSIGNED TO LIE
Jan 8, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 17, 2019 TROA
REFUSAL PROCESSED BY IB
Aug 2, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 13, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jul 12, 2019 RFRR
APPLICATION FILING RECEIPT MAILED
Jun 26, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 25, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jun 24, 2019 CNRT
ASSIGNED TO EXAMINER
Jun 22, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 22, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 20, 2019 REPR

Related Trademarks

More from this Owner

OBDIELA

OBDIELA

LIFVAYTA

LIFVAYTA

GENFIT TOWARDS BETTER MEDICINE logo

GENFIT TOWARDS BETTER MEDICINE

GENFIT TOWARDS BETTER MEDICINE logo

GENFIT TOWARDS BETTER MEDICINE

GENFIT TOWARDS BETTER MEDICINE logo

GENFIT TOWARDS BETTER MEDICINE

GENFIT TOWARDS BETTER MEDICINE logo

GENFIT TOWARDS BETTER MEDICINE